Prestige Consumer Healthcare
PBH
#3940
Rank
A$4.50 B
Marketcap
A$91.56
Share price
1.27%
Change (1 day)
-30.51%
Change (1 year)

Revenue for Prestige Consumer Healthcare (PBH)

Revenue in 2025 (TTM): A$1.73 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current revenue (TTM ) is A$1.67 Billion. In 2024 the company made a revenue of A$1.79 Billion an increase over the revenue in the year 2023 that were of A$1.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prestige Consumer Healthcare from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$1.73 B-3.45%
2024 A$1.79 B7.99%
2023 A$1.66 B2.18%
2022 A$1.62 B11.69%
2021 A$1.45 B17.24%
2020 A$1.24 B-8.56%
2019 A$1.36 B-3.23%
2018 A$1.40 B7.02%
2017 A$1.31 B11.53%
2016 A$1.17 B8.86%
2015 A$1.08 B32.43%
2014 A$0.81 B19.73%
2013 A$0.68 B17.62%
2012 A$0.58 B47.49%
2011 A$0.39 B28.3%
2010 A$0.30 B-7.05%
2009 A$0.32 B-27.25%
2008 A$0.45 B22.31%
2007 A$0.37 B-8.82%
2006 A$0.40 B0.87%
2005 A$0.40 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
GlaxoSmithKline
GSK
A$63.76 B 3,713.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$94.52 B 5,553.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
A$35.34 B 2,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$138.73 B 8,198.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$0.91 B-44.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$84.86 B 4,976.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
A$127.86 B 7,548.32%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$593.29 B 35,387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$10.19 B 509.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$66.00 B 3,848.12%๐Ÿ‡บ๐Ÿ‡ธ USA